CHARYBDIS
Project CHARYBDIS (Characterizing Health Associated Risks, and Your Baseline Disease In SARS-COV-2) studies the disease natural history of COVID-19. It attempts to describe the baseline demographics, clinical characteristics, treatments, symptoms and outcomes of interest among individuals with COVID-19 overall and stratified by sex, age and specific comorbidities. Kristin Kostka (IQVIA) shared this update (see right) on the project, including a brief discussion on some topics of interest as the team prepares for CHARYBDIS 2.0.
CHARYBDIS Presentation Slides